100 related articles for article (PubMed ID: 25764831)
21. Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity.
Jayakumar S; Kunwar A; Sandur SK; Pandey BN; Chaubey RC
Biochim Biophys Acta; 2014 Jan; 1840(1):485-94. PubMed ID: 24121106
[TBL] [Abstract][Full Text] [Related]
22. Chromosome damage and cell proliferation rates in in vitro irradiated whole blood as markers of late radiation toxicity after radiation therapy to the prostate.
Beaton LA; Ferrarotto C; Marro L; Samiee S; Malone S; Grimes S; Malone K; Wilkins RC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1346-52. PubMed ID: 23158059
[TBL] [Abstract][Full Text] [Related]
23. [The connection between molecular-cellular parameters and immune status of liquidators after Chernobyl accident].
Pelevina II; Oradovskaia IV; Mansurova IuG; Aleshchenko AV; Antoshchina MM; Kudriashova OV; Lizunova EIu; Nikonova MF; Osipov AN; Riabchenko NI; Feoktistov VV; Serebrianyĭ AM
Radiats Biol Radioecol; 2010; 50(5):501-7. PubMed ID: 21260999
[TBL] [Abstract][Full Text] [Related]
24. [Cytogenetic effects of low dose radiation with different LET in human peripheral blood lymphocytes and possible mechanisms of their realization].
Nasonova EA; Shmakova NL; Komova OV; Mel'nikova LA; Fadeeva TA; Krasavin EA
Radiats Biol Radioecol; 2006; 46(4):457-60. PubMed ID: 17020097
[TBL] [Abstract][Full Text] [Related]
25. Prediction of radiation-induced toxicity by in vitro radiosensitivity of lymphocytes in prostate cancer patients.
Pinkawa M; Brzozowska K; Kriehuber R; Eble MJ; Schmitz S
Future Oncol; 2016 Mar; 12(5):617-24. PubMed ID: 26806671
[TBL] [Abstract][Full Text] [Related]
26. In vitro radiosensitivity of peripheral blood lymphocytes in multiple sclerosis patients.
Petcu I; Savu D; Thierens H; Nagels G; Vral A
Int J Radiat Biol; 2006 Nov; 82(11):793-803. PubMed ID: 17148263
[TBL] [Abstract][Full Text] [Related]
27. Destabilization of human cell genome under the combined effect of radiation and ascorbic acid.
Domina EA; Pylypchuk OP; Mikhailenko VM
Exp Oncol; 2014 Dec; 36(4):236-40. PubMed ID: 25537216
[TBL] [Abstract][Full Text] [Related]
28. [Particularities of blood lymphocyte response to irradiation in vitro in breast cancer patients].
Vorob'eva NIu; Antonenko AV; Osipov AN
Radiats Biol Radioecol; 2011; 51(4):451-6. PubMed ID: 21950102
[TBL] [Abstract][Full Text] [Related]
29. [The adaptive response of first generation offsprings irradiated parents].
Akleev AV; Aleshchenko AV; Gotlib VIa; Kudriashova OV; Semenova LP; Serebrianyĭ AM; Khudiakova OI; Pelevina II
Radiats Biol Radioecol; 2007; 47(5):550-7. PubMed ID: 18051680
[TBL] [Abstract][Full Text] [Related]
30. Adaptive response to ionizing radiation in normal and aneuploid human lymphocytes.
Kalina I; Konecná H; Némethová G; Raceková N
Folia Biol (Praha); 1994; 40(3):119-23. PubMed ID: 7805933
[TBL] [Abstract][Full Text] [Related]
31. Radiation-induced lymphocyte apoptosis to predict radiation therapy late toxicity in prostate cancer patients.
Schnarr K; Boreham D; Sathya J; Julian J; Dayes IS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1424-30. PubMed ID: 19167839
[TBL] [Abstract][Full Text] [Related]
32. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
Ebelt K; Babaryka G; Figel AM; Pohla H; Buchner A; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E
Prostate; 2008 Jan; 68(1):1-10. PubMed ID: 17948280
[TBL] [Abstract][Full Text] [Related]
33. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
Dunst J; Gebhart E; Neubauer S
Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
Gong P; Zhang T; He D; Hsieh JT
Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
[TBL] [Abstract][Full Text] [Related]
35. Atorvastatin prolongs the lifespan of radiation‑induced reactive oxygen species in PC-3 prostate cancer cells to enhance the cell killing effect.
Yu H; Sun SQ; Gu XB; Wang W; Gao XS
Oncol Rep; 2017 Apr; 37(4):2049-2056. PubMed ID: 28260074
[TBL] [Abstract][Full Text] [Related]
36. [The cell composition in the lymphocyte population and the radiation adaptive response].
Serebrianyĭ AM; Aleshchenko AV; Gotlib VIa; Kudriashova OV; Semenova LP; Pelevina II
Tsitologiia; 2003; 45(1):81-5. PubMed ID: 12683240
[TBL] [Abstract][Full Text] [Related]
37. [Apoptosis of peripheral lymphocytes of healthy donors and patients with laryngeal neoplasms after gamma-irradiation in vitro].
Orlova NV; Smirnova SG; Zamulaeva IA; Andreev VG; Riabchenko NI; Saenko AS
Radiats Biol Radioecol; 2001; 41(4):366-72. PubMed ID: 11605235
[TBL] [Abstract][Full Text] [Related]
38. Radiotoxicity after strontium-89 therapy for bone metastases using the micronucleus assay.
Watanabe N; Yokoyama K; Kinuya S; Shuke N; Shimizu M; Michigishi T; Tonami N; Seto H; Goodwin DA
J Nucl Med; 1998 Dec; 39(12):2077-9. PubMed ID: 9867144
[TBL] [Abstract][Full Text] [Related]
39. [An estimation of individual radiosensitivity prostate malignant tumour cells using dynamic control of prostatic specific antigen level].
Minaeva NG; Parshkov EM; Golivets TP; Artamonova IuZ
Radiats Biol Radioecol; 2009; 49(4):444-8. PubMed ID: 19799366
[TBL] [Abstract][Full Text] [Related]
40. Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients.
Sage EK; Schmid TE; Geinitz H; Gehrmann M; Sedelmayr M; Duma MN; Combs SE; Multhoff G
Strahlenther Onkol; 2017 Aug; 193(8):648-655. PubMed ID: 28500490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
